Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Stock Report

| More

Kilitch Drugs to set-up second green field Project in Ethiopia at an investment of USD 5 mn

Posted On: 2019-12-09 13:27:35

Government of Ethiopia in its endeavor to become self-sufficient has invited Kilitch to explore supply of Liquid injectables. After considering the request and opportunity, Kilitch Drugs, is setting up its second green field project in Ethiopia to manufacture liquid injectables and at a capital investment of USD 5 million. In this regard, the Company has accepted the request of Ethiopian government for one hector land near Addis Ababa.

At the same time, the Company's first manufacturing plant has also reached a decisive stage of the completion process. Kilitch Drugs has begun installing machinery at the first Addis Ababa manufacturing unit and is all scheduled to commence the validation process this month (December). Process validation being an important tool in quality management of pharmaceuticals is a significant parameter of GMPs. Process validation helps ensure production of drug of a reproducible quality. Further, this also ensures that the quality assurance techniques used to build the quality into the product at every step is up to the desired standards.

Commenting on the company's project status, Mr. Bhavin Mehta, Whole time Director of Kilitch Drugs said, "We are happy to announce our second manufacturing venture in Ethiopia as also for the maiden unit which is now at a very critical stage of our project implementation cycle. Once the validation process is satisfactorily done, Kilitch Drugs plans to commence operations at the first unit in the first quarter of FY2020-21. Overall, our expansion plans will be involving a capital expenditure of Rs. 42.60 crs @ Rs. 71per USD (existing plus incremental USD 6 mn) are as per schedule. We are confident that manufacturing base in Ethiopia will strengthen our presence in the African continent."

Kilitch Drugs has registered over 300 products in key African countries and another 250+ products are under registration. It has been having a presence in Africa for over three decades now and during this period has gained a strong advantage. About 80% of company's revenues come from African operations. Ethiopia has been a center of focus for the company and it has been exporting and marketing drug formulations in solid, liquid and parenteral dosage forms. Kilitch Drugs is bullish on the African markets and is expecting revenues to the tune of Rs 500 crs, in the next five years. The company's hopes to replicate its Ethiopian business model to the rest of Africa, going forward.

Shares of KILITCH DRUGS (INDIA) LTD. was last trading in BSE at Rs.116.4 as compared to the previous close of Rs. 114.3. The total number of shares traded during the day was 171 in over 19 trades.

The stock hit an intraday high of Rs. 116.65 and intraday low of 114.15. The net turnover during the day was Rs. 19841.

Source: Equity Bulls

Click here to send ur comments or to

Other Headlines:

Paushak Limited receives approval for expanding production capacity of Phosgene to 14,400 MTPA

Thomas Cook (India) Limited announces results for Q1 FY21

Info Edge India Ltd fixes floor price of QIP as Rs. 3177.18

LIC ups stake in YES Bank to 4.989% through market purchase

Persistent Receives 2020 Workato Partner Award for Innovation

Infosys USA certified as Great Place To Work®

Eris Lifesciences Ltd Board declares Interim Dividend of Rs. 5.50

Thomas Cook India Ltd Q1FY21 consolidated loss at Rs. 94.20 crore

PTC India Financial Services Ltd posts consolidated PAT of Rs. 26.56 crore

Sun Pharma Advanced Research Company Ltd Q1FY21 PAT at Rs. 56.69 crore

MRPL Q1 consolidated loss at Rs. 719.78 crore

ITC's Paperboards Unit at Bhadrachalam conferred with GreenCo Platinum+ rating by CII Green Business Centre for its Environmental Stewardship

NMDC registers record jump in production and sales of iron ore in July 2020

Titan Eyeplus in association with Sankara Nethralaya, Chennai launches Teleconsultation Eye care Services for its customers across the country

JSPL Felicitates its COVID-19 warriors

IndiGo repatriated 212 Indians citizens from Russia

Axis Bank Limited announces opening of QIP, floor price fixed as Rs. 442.19

Narayana Hrudalaya Ltd Q1 FY21 Consolidated operating income at Rs 3,935 mn

Tata Consumer Products Ltd announces results for the quarter ended 30th June 2020

Geojit Announces Appointment of Alice G. Vaidyan to the Board

Maruti Suzuki - Delivering sustainable growth through inclusive approach

ASM Technologies Ltd Board recommends interim dividend of Rs. 2

Digitate Launches ignio™ AI.Assurance to Transform Software Testing and Speed Up Software Release Cycles

Lupin Receives Tentative Approval for Empagliflozin Tablets

Sun Pharma launches FluGuard® (Favipiravir) in India at Rs. 35 per tablet

PI Industries Ltd posts consolidated net profit of Rs. 145.5 crore

Tata Consumer Products Ltd Q1FY20 consolidated PAT surges to Rs. 327.56 crore

Zim Laboratories Ltd Q1 consolidated PAT soars to Rs. 3.28 crore

Uniphos Enterprises Ltd posts Rs. 0.25 crore PAT in Q1FY21

Jenburkt Pharmaceuticals Ltd Q1 PAT at Rs. 1 crore

Gujarat Gas Ltd reports Rs. 59.07 crore consolidated PAT in Q1FY21

Unichem Laboratories Ltd Q1FY21 consolidated net profit at Rs. 2.43 crore

Astral Poly Technik Ltd Q1FY21 consolidated PAT falls

Tamilnadu Petroproducts Ltd Q1 consolidated PAT rises QoQ, drops YoY

Geojit Financial Services Ltd Q1FY21 consolidated net profit jumps to Rs. 23.84 crore

Century Enka Ltd posts Rs. 24.90 crore loss in Q1FY21

Vinyl Chemicals India Ltd reports higher net profit of Rs. 1.16 crore in Q1FY21

Bhansali Engineering Polymers Ltd Q1 consolidated loss at Rs. 1.38 crore

Gujarat Sidhee Cement Ltd reports Rs. 4.98 crore consolidated PAT in Q1

Atishay Ltd posts Q1FY21 net profit of Rs. 0.58 crore

Godrej Consumer Products Ltd Q1FY21 consolidated PAT rises QoQ basis

ASM Technologies Ltd Q1FY21 consolidated PAT at Rs. 3.70 crore

Igarashi Motors India Ltd Q1FY21 loss at Rs. 10.52 crore

HIKAL Ltd Q1FY21 consolidated PAT at Rs. 15 crore

Varun Beverages Ltd Board declares Interim Dividend of Rs. 2.50 for CY2020

Deccan Cements Ltd board to announce Q1 results on Aug 14, 2020

Berger Paints India Ltd board to approve quarterly results on Aug 14, 2020

Marksans Pharma Ltd Q1FY21 Revenue at Rs. 331.3 Cr

Ashok Leyland subsidiary Optare delivers first of 21 battery-electric Metrodecker EV with First York

Ashwini Kumar Tewari Takes Charge as The Managing Director and CEO of SBI Card

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019